ARCHIVES

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

This article is from The Cancer Letter archive.

Vol. 24 No. 34 | September 11, 1998

Download PDF Visit The Full Archive

Related Articles

Sen. Pryor Attacks Drug Industry, NIH Technology Transfer

March 5, 1993

MGI Pharma, MethylGene Begin Phase II Trial Of MG98.

September 28, 2001

NIH Deputy Director Ruth Kirschstein Plans Transition To Senior Advisor

October 4, 2002

Cancer Policy: President’s Cancer Panel Issues Statement On National Cancer Program

September 17, 1999

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976